Molecule Trader
Subscribe
Sign in
When Wall Street Gets Biotech Wrong
Ten FDA decisions, ten very different share-price reactions, and what investors should look for before the next PDUFA date
Aug 6
•
Molecule Trader
1
July 2026
MannKind
The July FDA Trade, the Real Cash Runway and What the Market May Be Missing
Jul 18
•
Molecule Trader
1
1
Viking Therapeutics
The obesity biotech that now has to prove it can become a company
Jul 10
•
Molecule Trader
2
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts